HCA Healthcare (HCA) Receives a Hold from Wells Fargo

Wells Fargo analyst Steve Baxter maintained a Hold rating on HCA Healthcare (HCAResearch Report) today and set a price target of $227.00. The company’s shares closed last Monday at $210.93.

According to, Baxter is a 1-star analyst with an average return of -2.7% and a 52.4% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Universal Health, and Community Health.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for HCA Healthcare with a $263.29 average price target, representing a 26.3% upside. In a report issued on April 22, Barclays also maintained a Hold rating on the stock with a $256.00 price target.

See the top stocks recommended by analysts >>

The company has a one-year high of $279.02 and a one-year low of $196.22. Currently, HCA Healthcare has an average volume of 1.64M.

Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCA in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Founded in 1968, HCA Healthcare, Inc. is a healthcare services company, based in Tennessee. The company operates general and psychiatric hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It also offers a full range of services to accommodate medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.

Read More on HCA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More